A Novel <em>DNMT3A</em> R882H Cell Line Generated Using CRISPR/Cas9 Technology as a Universal Quality Control Material for Clinical Testing in Acute Myeloid Leukemia

doi:10.13865/j.cnki.cjbmb.2021.07.1228

A Novel DNMT3A R882H Cell Line Generated Using CRISPR/Cas9 Technology as a Universal Quality Control Material for Clinical Testing in Acute Myeloid Leukemia

WANG Ning,WEI Ya-Li,AN Xu,CAO Qin-Mei,ZHOU Rui

Chinese Journal of Biochemistry and Molecular Biology ›› 2021, Vol. 37 ›› Issue (8) : 1118-1123.

PDF(2567 KB)

Chinese Journal of Biochemistry and Molecular Biology ›› 2021, Vol. 37 ›› Issue (8) : 1118-1123. DOI: 10.13865/j.cnki.cjbmb.2021.07.1228

Research Papers

A Novel DNMT3A R882H Cell Line Generated Using CRISPR/Cas9 Technology as a Universal Quality Control Material for Clinical Testing in Acute Myeloid Leukemia

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2021, 37(8): 1118-1123 https://doi.org/10.13865/j.cnki.cjbmb.2021.07.1228

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

Funding

RIGHTS & PERMISSIONS

PDF(2567 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Revised	Published
2021-04-25	2021-06-17	2021-08-20
Issue Date
2021-08-17

Please choose a citation manager

Content to export